OLX-10010

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameOLX-10010
Drug Alias NameBMT-101OLX-101OLX-10010cp-asiCTGFOLX-101A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionConnective tissue growth factor inhibitorsRNA interference
TargetsConnective tissue growth factor
Therapy Area/IndicationsCicatrix, HypertrophicWet age-related macular degenerationMacular Degeneration +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited KingdomSouth Korea
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesOlix Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesOlix Pharmaceuticals Inc
Inactive CompaniesHugel Inc
Active IndicationsCicatrix, HypertrophicWet age-related macular degenerationMacular Degeneration +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A